266
Views
0
CrossRef citations to date
0
Altmetric
Studies in Humans

Long-term effects of varying consumption of ω3 fatty acids in ear, nose and throat cancer patients: assessment 1 year after radiotherapy

, , , , , , , , & show all
Pages 108-113 | Received 01 May 2014, Accepted 07 Aug 2014, Published online: 29 Sep 2014

References

  • Ali EM, Abdelraheem AG. 2011. Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck Oncol 3:48–53
  • Baynes JW. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412
  • Bechoua S, Dubois M, Dominguez Z, Goncalves A, Némoz G, Lagarde M, Prigent AF. 1999. Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol 57:1021–1030
  • Borek C. 2004. Free radicals: the pros and cons of antioxidants. Antioxidants and radiation therapy 1. J Nutr 134:3207–3209
  • Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M. 2012. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal 17:e10–e15
  • Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G, Baracos V. 2003. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia / cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21:129–134
  • Calviello G, Serini S, Piccioni E, Pessina G. 2009. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 61:287–301
  • Cerantola Y, Hübner M, Grass F, Demartines N, Schäfer M. 2011. Immunonutrition in gastrointestinal surgery. Br J Surg 98:37–48
  • Chen B, Rao X, House MG, Nephew KP, Cullen KJ, Guo Z. 2011. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett 309:37–45
  • Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF. 2011. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol 36:147–153
  • Chencharick JD, Mossman KL. 1983. Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 51:811–815
  • Dahiya K, Dhankhar R, Madaan H, Singh V, Arora K. 2012. Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy. Ann Clin Lab Sci 42:94–97
  • Dhankhar R, Dahiya K, Sharma TK, Ghalaut VS, Atri R, Kaushal V. 2011. Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma. Clin Lab 57:795–798
  • FAO. 2010. Fats and fatty acids in human nutrition: report of an expert consultation. FAO Food and Nutrition Paper 91: 15. ISBN: 978-92-5-306733-6
  • Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, et al. 2003. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:1479–1486
  • Felekis D, Eleftheriadou A, Papadakos G, Bosinakou I, Ferekidou E, Kandiloros D, Katsaragakis S, et al. 2010. Effect of perioperative immuno-enhanced enteral nutrition on inflammatory response, nutritional status, and outcomes in head and neck cancer patients undergoing major surgery. Nutr Cancer 62:1105–1112
  • Fridlyand LE, Philipson LH. 2005. Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 1066:136–151
  • Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, et al. 2011. Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck 33:1606–1615
  • Helzlsouer KJ, Erlinger TP, Platz EA. 2006. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 42:704–707
  • Hodapp N. 2012. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Oncol 188:97–99
  • Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, Windeler J, et al. 1995. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 23:652–659
  • Koom WS, Ahn SD, Song SY, Lee CG, Moon SH, Chie EK, Jang HS, et al. 2012. Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J 30:132–139
  • Korde SD, Basak A, Chaudhary M, Goyal M, Vagga A. 2011. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 80:382–389
  • Liu Z, Li S, Cai Y, Wang A, He Q, Zheng C, Zhao T, et al. 2012. Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med 53:44–50
  • Machon C, Thezenas S, Dupuy AM, Assenat E, Michel F, Mas E, Senesse P, Cristol JP. 2012. Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer 20:3129–3135
  • Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J, Jabbari MV. 2007. Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J 28:435–440
  • Martí-Cid R, Bocio A, Domingo JL. 2007. Laboratorio de Toxicología i Salud Medioambiental, URV. Available at: http://130.206.36.67/ribefood/index.php?l=es. Accessed on December 2007
  • Martín-Villares C, San Román-Carbajo J, Fernández-Pello ME, Tapia Risueño M, Domínguez Calvo J. 2003. Nutritional status in head and neck cancer patients: the impact on the prognosis. Nutr Hosp 18:91–94
  • McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, et al.; A.S.P.E.N. Board of Directors; American College of Critical Care Medicine; Society of Critical Care Medicine. 2009. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33:277–316
  • Michalowski AS. 1994. On radiation damage to normal tissues and its treatment. Anti-inflammatory drugs. Acta Oncol 33:139–157
  • Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, Ghaderi A. 2011. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res 17:7–10
  • Moses AW, Slater C, Preston T, Barber MD, Fearon KC. 2004. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996–1002
  • Nibali L, Fedele S, D'Aiuto F, Donos N. 2012. Interleukin-6 in oral diseases: a review. Oral Diseases 18:236–243
  • Park KS, Lim JW, Kim H. 2009. Inhibitory mechanism of n-3 fatty acids in pancreatic inflammation and apoptosis. Ann N Y Acad Sci 1171:421–427
  • Peter F, Wittekindt C, Finkensieper M, Kiehntopf M, Guntinas-Lichius O. 2013. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. J Cancer Res Clin Oncol 139:171–178
  • Peters LJ. 1996. Radiation therapy tolerance limits. For one or for all? Cancer 77:2379–2385
  • Reddy VS, Dakshinamurty KV, Sherke RL, Neela T. 2002. N-3 Polyunsaturated fatty acids in the prevention of progression of chronic renal disease. Indian J Nephrol 12:6–9
  • Righini CA, Timi N, Junet P, Bertolo A, Reyt E, Atallah I. 2013. Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 130:8–14
  • Roca-Rodríguez MM, García-Almeida JM, Lupiañez-Pérez Y, Rico JM, Toledo M, Alcaide-Torres J, Cardona F, et al. 2014. Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients. Oncol Rep 31:405–414
  • Ruxton CH, Reed SC, Simpson MJ, Millington KJ. 2007. The health benefits of n-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 20:275–285
  • Sarsilmaz M, Songur A, Ozyurt H, Kuş I, Ozen OA, Ozyurt B, Söğüt S, Akyol O. 2003. Potential role of dietary ω-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 69:253–259
  • Sharma PK, Dwarakanath BS, Varshney R. 2012. Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells. Free Radic Biol Med 53:1500–1513
  • Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, et al. 2009. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 4:e6377
  • Somani N, Goyal S, Pasricha R, Khuteta N, Agarwal P, Garg AK, Singhal H. 2011. Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients – single institute experience. Indian J Med Paediatr Oncol 32:86–91
  • Sorensen D, McCarthy M, Baumgartner B, Demars S. 2009. Perioperative immunonutrition in head and neck cancer. Laryngoscope 119:1358–1364
  • Sultan J, Griffin SM, Di Franco F, Kirby JA, Shenton BK, Seal CJ, Davis P, et al. 2012. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99:346–355
  • US National Institute of Health. National Cancer Institute Common Toxicity Criteria. Available at: https://www.ucdmc.ucdavis.edu/clinicaltrials/StudyTools/Documents/NCI_Toxicity_Table.pdf. Accessed on 21 August 2014
  • Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. 2011. IL-6 promotes head and neck tumor metastasis by inducing epithelial–mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9: 1658–1667
  • Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Wu R. 2012. C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy. Tumour Biol 33:891–895
  • Ziech D, Franco R, Pappa A, Panayiotidis MI. 2011. Reactive oxygen species (ROS) induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711:167–173

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.